APA (7th ed.) Citation

JK, K., I, T., K, A., M, M., V, G., & MO, J. (2024). Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report. Journal of investigative medicine high impact case reports, 12, 23247096241231645. https://doi.org/10.1177/23247096241231645

Chicago Style (17th ed.) Citation

JK, Khatri, Tahboub I, Anwar K, Masoudi M, Graffeo V, and Jamil MO. "Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report." Journal of Investigative Medicine High Impact Case Reports 12 (2024): 23247096241231645. https://doi.org/10.1177/23247096241231645.

MLA (9th ed.) Citation

JK, Khatri, et al. "Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report." Journal of Investigative Medicine High Impact Case Reports, vol. 12, 2024, p. 23247096241231645, https://doi.org/10.1177/23247096241231645.